Keros Therapeutics, Inc. Annual Operating Margin in % from 2019 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Keros Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2024.
  • Keros Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -5.94K %, a 94.7% increase year-over-year.
  • Keros Therapeutics, Inc. annual Operating Margin for 2024 was -5.94K %, a 94.7% increase from 2023.
  • Keros Therapeutics, Inc. annual Operating Margin for 2023 was -113K %.
  • Keros Therapeutics, Inc. annual Operating Margin for 2021 was -280K %.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -5.94K +107K +94.7% Jan 1, 2024 Dec 31, 2024
2023 -113K Jan 1, 2023 Dec 31, 2023
2021 -280K Jan 1, 2021 Dec 31, 2021
2019 -106 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.